Skip to main
PACS

PACS Stock Forecast & Price Target

PACS Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PACS Group is favorably positioned in the post-acute healthcare market, with a leading position in the skilled nursing facility sector and strong tailwinds from an aging population and a shift towards value-based care. Its decentralized operating model and strong financial flexibility, along with its focus on strategic acquisitions, should drive continued growth and value creation for the company. Management's conservative approach to maintaining low leverage and focusing on operational improvement mitigates any regulatory risks and potential stock divestment.

Bears say

PACS Group is expected to see an increase in adjusted EBITDA in 2026 and 2027, as reflected by their updated guidance and raised estimates. However, the risks associated with reimbursement pressures, staffing challenges, and concentrated operations pose a threat to their position and may result in reduced profitability. Investors should be cautious and closely monitor these factors before making any investment decisions.

PACS has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PACS Group, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PACS Group, Inc. (PACS) Forecast

Analysts have given PACS a Buy based on their latest research and market trends.

According to 5 analysts, PACS has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $54.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $54.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PACS Group, Inc. (PACS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.